Results 121 to 130 of about 12,342 (188)

Peripheral Parasympathetic Networks in Pain: A Systems-Level Review of Mechanisms and Modulations. [PDF]

Cell Mol Neurobiol
Yang R, Jia S, Li Y, Yang H, Han Z, Liang L, Huang F, Fan W.   +7 more
europepmc   +1 more source

Investigations into the basal neural-like properties of dental pulp stem cells reveal they possess a functional type 2 muscarinic receptor which regulates quiescence. [PDF]

Stem Cell Res Ther
Alqahtani S, Gibbs A, Verma M, Baradwan O, Jubiar K, Alonazi MA, McLean W, Nile CJ.   +7 more
europepmc   +1 more source

Evidence for M2 Muscarinic Receptor Antagonist Delay of Myopia Development Through Activation of Kir3.4 Channel in the Retina of Guinea Pigs. [PDF]

Invest Ophthalmol Vis Sci
Zhou H, Zhou G, Yang Q, Niu J, Wang R, Liu H, Hou S, Bi H, Liao X.   +8 more
europepmc   +1 more source

Mechanisms of Pilocarpine-Induced Nitric Oxide and Prostaglandin Production in Porcine Ciliary Muscle. [PDF]

FASEB Bioadv
Benozzi G, Quinteros Villarruel E, Zuluaga AF, Orman B.   +3 more
europepmc   +1 more source

Mechanisms of Baishao () and Gancao () on major depressive disorder: network pharmacology and o validation. [PDF]

J Tradit Chin Med
Ke P, Yong LI, Zhe L, Guangfu L.
europepmc   +1 more source

Effects of Rosa damascena and its compounds on smooth muscle contractility. [PDF]

J Smooth Muscle Res
Demirel S, Sinag IN.
europepmc   +1 more source

Adjunctive xanomeline/trospium in clozapine-resistant schizophrenia: two case reports demonstrating limited response. [PDF]

Ther Adv Psychopharmacol
Dang VM, Powers JM, Markota M, Leung JG.
europepmc   +1 more source

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale. [PDF]

Geriatr Gerontol Int
Mogi M, Liu S, Suzuki Y, Shibata Y, Yamada S.   +4 more
europepmc   +1 more source

Research progress in myocardial function and diseases related to muscarinic acetylcholine receptor (Review). [PDF]

Int J Mol Med
Shen C, Zuo Q, Shao Z, Lin Y, Chen S.
europepmc   +1 more source

Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activation. [PDF]

Cardiovasc Res
Jani NR, van Weperen VYH, Ayagama T, Hoang JD, Emamimeybodi M, Bussmann BM, Bal S, Kumar A, Khaky A, Hamon D, Herring N, Smith C, Vaseghi M.   +12 more
europepmc   +1 more source